# Dilated Cardiomyopathy - Unknown Therapeutic Risk Reduction by Contempary Medication and Implantable Cardioverter-Defibrillators (DUTCH-ICD)

Study · id `cardio:ct-nct07415642` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07415642](<https://clinicaltrials.gov/study/NCT07415642>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07415642

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 720 participants.

## Technical summary

Registry record NCT07415642. Randomized; quadruple masking; primary purpose treatment. Start 2026-03-01 (anticipated); primary completion 2032-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 720 participants (planned count; ClinicalTrials.gov record NCT07415642, source copy `cardio:ctgov-nct07415642-2026-02-17`, retrieved 2026-10-26)
- Planned start: 2026-03-01 (anticipated) (ClinicalTrials.gov record NCT07415642, source copy `cardio:ctgov-nct07415642-2026-02-17`, retrieved 2026-10-26)
- Primary completion: 2032-12-31 (anticipated) (ClinicalTrials.gov record NCT07415642, source copy `cardio:ctgov-nct07415642-2026-02-17`, retrieved 2026-10-26)
- Completion: 2032-12-31 (anticipated) (ClinicalTrials.gov record NCT07415642, source copy `cardio:ctgov-nct07415642-2026-02-17`, retrieved 2026-10-26)
- Countries: Netherlands (ClinicalTrials.gov record NCT07415642, source copy `cardio:ctgov-nct07415642-2026-02-17`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07415642-2026-02-17`, retrieved 2026-10-26)

## The registry's words

- Brief title: Dilated Cardiomyopathy - Unknown Therapeutic Risk Reduction by Contempary Medication and Implantable Cardioverter-Defibrillators (DUTCH-ICD)
- Acronym: DUTCH-ICD
- Condition: Sudden Cardiac Death
- Intervention (Device): ICD implantation
- Lead sponsor: University Medical Center Groningen
- Lead sponsor class: OTHER
- Collaborator: Amsterdam University Medical Center
- Collaborator class: OTHER
- Collaborator: Radboud University Medical Center
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Sudden cardiac arrest (`cardio:sudden-cardiac-arrest`)
- Registry lists this organization as the lead sponsor: University Medical Center Groningen (`cardio:org-university-medical-center-groningen`)
- Registry lists this organization as a collaborator: Radboud University Medical Center (`cardio:org-radboud-university-medical-center`)

## Provenance

Content hash: 18d5a290a5abfeb6810b9f3793e009f1eb69b4b7d8d1b67e5b97e6eb0b807a19
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
